CLARIDEX

This brand name is authorized in Nigeria.

Active ingredients

The drug CLARIDEX contains one active pharmaceutical ingredient (API):

1	Clarithromycin UNII H1250JIK0A - CLARITHROMYCIN
	Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria.
	Read more about Clarithromycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-9083	Tablet	CLARIDEX-500 TABLET CLARITHROMYCIN 500MG TAB 500 mg 2 X 7	35 CMS-PP-406563 CLARIDEX-500 TABLET CLARITHROMYCIN 500MG CLARITHROMYCIN 500 MG LACTOSE MONOHYDRATE, MICROCRYSTALLINE CELLULOSE, CROSCARMELLOSE SODIUM, POVIDONE K- 30, PURIFIED WATER, PURIFIED TALC MAGNESIUM STEARATE, SPRAYCEL SC-2199 QUINOLINE YELLOW ISOPROPYL ALCOHOL, DICHLOROMETHANE A4-9083 Drugs Imported Products 2X7 TABLETS Prescription Only Medicine (POM) GENEITH PHARMACEUTICALS LIMITED, 12 ADEWALE CRESCENT, OFF EWENLA STREET, OSHODI, ISOLO, LAGOS 8122912281 ngouzoamaka@yahoo.com NOVAGEN HEALTHCARE PVT. LTD, PLOT NO. 102-111, HORIZON IND. PARK, N.H. NO.48 AT: BAMANGAM, DIST-VADODARA-391 243 GUJARAT STATE, INDIA., India	30/04/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA09	Clarithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-9083